Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-12-09 00:00:00 ET · period of report 2025-12-05 · accession 0001607737-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | 2025-12-05 | JAZZ | GALA RENEE D | Pres, CEO | F - Tax | $166.91 | -80 | 107.9K | -0.1% | -$13.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-12-05 | F | D | 80 | $166.91 | 107,860 | D | — | — | (F1) The Reporting Person acquired 71 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025. |